Cargando…

NS1 DNA vaccination protects against Zika infection through T cell–mediated immunity in immunocompetent mice

The causal association of Zika virus (ZIKV) with microcephaly, congenital malformations in infants, and Guillain-Barré syndrome in adults highlights the need for effective vaccines. Thus far, efforts to develop ZIKV vaccines have focused on the viral envelope. ZIKV NS1 as a vaccine immunogen has not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grubor-Bauk, B., Wijesundara, D. K., Masavuli, M., Abbink, P., Peterson, R. L., Prow, N. A., Larocca, R. A., Mekonnen, Z. A., Shrestha, A., Eyre, N. S., Beard, M. R., Gummow, J., Carr, J., Robertson, S. A., Hayball, J. D., Barouch, D. H., Gowans, E. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905874/ https://www.ncbi.nlm.nih.gov/pubmed/31844662 http://dx.doi.org/10.1126/sciadv.aax2388

Ejemplares similares

Enhanced T Cell Responses Induced by a Necrotic Dendritic Cell Vaccine, Expressing HCV NS3
por: Mekonnen, Zelalem A., et al.
Publicado: (2020)

Safety Profile of a Multi-Antigenic DNA Vaccine Against Hepatitis C Virus
por: Gummow, Jason, et al.
Publicado: (2020)

Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines
por: Shrestha, Ashish C., et al.
Publicado: (2019)

Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2017)

Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine
por: Wijesundara, Danushka K., et al.
Publicado: (2023)

Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses
por: Tomusange, Khamis, et al.
Publicado: (2016)

Toward DNA-Based T-Cell Mediated Vaccines to Target HIV-1 and Hepatitis C Virus: Approaches to Elicit Localized Immunity for Protection
por: Mekonnen, Zelalem A., et al.
Publicado: (2019)

A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice
por: Tomusange, Khamis, et al.
Publicado: (2016)

Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1
por: Wijesundara, Danushka K., et al.
Publicado: (2017)

Cytolytic DNA vaccine encoding lytic perforin augments the maturation of- and antigen presentation by- dendritic cells in a time-dependent manner
por: Wijesundara, Danushka K., et al.
Publicado: (2017)

A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2019)

Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery
por: Christiansen, D., et al.
Publicado: (2019)

Hepatitis C virus drives the pathogenesis of hepatocellular carcinoma: from immune evasion to carcinogenesis
por: Canavese, Miriam, et al.
Publicado: (2016)

Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis
por: Fenix, Kevin, et al.
Publicado: (2020)

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
por: Ryan, Feargal J., et al.
Publicado: (2022)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
por: López-Camacho, César, et al.
Publicado: (2019)

SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents
por: Garcia-Valtanen, Pablo, et al.
Publicado: (2022)

Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein
por: Gargett, Tessa, et al.
Publicado: (2014)

Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and mice
por: Larocca, Rafael A., et al.
Publicado: (2021)

A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model
por: Brault, Aaron C., et al.
Publicado: (2017)

Identification of Key Residues in Dengue Virus NS1 Protein That Are Essential for Its Secretion
por: Tan, Brandon E. K., et al.
Publicado: (2023)

Zika Virus Targeting by Screening Inhibitors against NS2B/NS3 Protease
por: Choudhry, Hani, et al.
Publicado: (2019)

Structures of NS5 Methyltransferase from Zika Virus
por: Coloma, Javier, et al.
Publicado: (2016)

Three Immunocompetent Small Animal Models That Do Not Support Zika Virus Infection
por: Miller, Megan R., et al.
Publicado: (2021)

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine
por: Christiansen, D., et al.
Publicado: (2018)

Mapping Putative B-Cell Zika Virus NS1 Epitopes Provides Molecular Basis for Anti-NS1 Antibody Discrimination between Zika and Dengue Viruses
por: Freire, Marjorie C. L. C., et al.
Publicado: (2017)

Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease
por: Kumar, Ankur, et al.
Publicado: (2018)

C-Terminal Extended Hexapeptides as Potent Inhibitors of the NS2B-NS3 Protease of the ZIKA Virus
por: Pant, Suyash, et al.
Publicado: (2022)

The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates
por: Prow, Natalie A., et al.
Publicado: (2020)

A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
por: Prow, Natalie A., et al.
Publicado: (2018)

Molecular docking and simulation of Zika virus NS3 helicase
por: Badshah, Syed Lal, et al.
Publicado: (2019)

Therapeutic Potential of Antiviral Peptides against the NS2B/NS3 Protease of Zika Virus
por: Hossain, Md. Shahadat, et al.
Publicado: (2023)

Vaccine Protection Against Zika Virus from Brazil
por: Larocca, Rafael A., et al.
Publicado: (2016)

The immunodominant antibody response to Zika virus NS1 protein is characterized by cross-reactivity to self
por: Cavazzoni, Cecilia B., et al.
Publicado: (2021)

Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge
por: Cox, Freek, et al.
Publicado: (2018)

TRIM22 suppresses Zika virus replication by targeting NS1 and NS3 for proteasomal degradation
por: Zu, Shulong, et al.
Publicado: (2022)

High Throughput Screening Targeting the Dengue NS3-NS5 Interface Identifies Antivirals against Dengue, Zika and West Nile Viruses
por: Yang, Sundy N. Y., et al.
Publicado: (2022)

Structure of NS3 helicase from Zika virus
por: Jain, Rinku, et al.
Publicado: (2016)

NS1 codon usage adaptation to humans in pandemic Zika virus
por: Freire, Caio César de Melo, et al.
Publicado: (2018)

Structure‐Based Macrocyclization of Substrate Analogue NS2B‐NS3 Protease Inhibitors of Zika, West Nile and Dengue viruses
por: Braun, Niklas J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hm5bdi0s0psjccqtnt6s58rjfu